Ashley Teusink-Cross
Overview
Explore the profile of Ashley Teusink-Cross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta P, Nelson A, Loveless S, Lane A, Fukuda T, Teusink-Cross A, et al.
Blood Adv
. 2025 Jan;
PMID: 39820512
Fanconi anemia (FA) is a rare inherited disorder characterized by progressive bone marrow failure (BMF) and a predisposition to malignancy. Systemic reactive-oxygen species (ROS) and increased sensitivity of FA hematopoietic...
2.
Merli P, Jodele S, Cook E, Myers K, Lane A, Ryhanen S, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):406-411.
PMID: 39627345
No abstract available.
3.
Shanthikumar S, Gower W, Srinivasan S, Rayment J, Robinson P, Bracken J, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(3):262-280.
PMID: 38889365
Many children undergo allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of malignant and nonmalignant conditions. Unfortunately, pulmonary complications occur frequently post-HSCT, with bronchiolitis obliterans syndrome (BOS) being the...
4.
Cook E, Dong M, Chiang S, Luedeke D, Lake K, Hoerth C, et al.
Transplant Cell Ther
. 2024 Feb;
30(5):528.e1-528.e12.
PMID: 38401793
We evaluated the pharmacokinetics (PK) of oral ruxolitinib in children with steroid-refractory acute graft-versus-host disease (aGVHD) (age <12 years) and chronic GVHD (cGVHD) (age ≤18 years) using our published pediatric...
5.
Khandelwal P, Langenberg L, Luebbering N, Lake K, Butcher A, Bota K, et al.
Blood
. 2024 Jan;
143(12):1181-1192.
PMID: 38227933
Vitamin A plays a key role in the maintenance of gastrointestinal homeostasis and promotes a tolerogenic phenotype in tissue resident macrophages. We conducted a prospective randomized double-blinded placebo-controlled clinical trial...
6.
Hudda Z, Flannery A, Teusink-Cross A, Davies S, Khandelwal P
Bone Marrow Transplant
. 2024 Jan;
59(3):425-427.
PMID: 38182673
No abstract available.
7.
Jodele S, Dandoy C, Aguayo-Hiraldo P, Lane A, Teusink-Cross A, Sabulski A, et al.
Blood
. 2023 Nov;
143(12):1112-1123.
PMID: 37946262
High-risk, complement mediated, untreated transplant-associated thrombotic microangiopathy (hrTMA) has dismal outcomes due to multi-organ dysfunction syndrome (MODS). The complement C5 blocker eculizumab shows promising results in hrTMA, but has not...
8.
Bartlett A, Zhang G, Wallace G, McLean S, Myers K, Teusink-Cross A, et al.
Blood Adv
. 2023 Jun;
7(16):4555-4562.
PMID: 37285801
Vitamin D deficiency is common in childhood, pervasive before and after bone marrow transplant, and is associated with increased incidence of graft-versus-host disease (GVHD) and decreased survival in patients undergoing...
9.
Ramsey L, Prows C, Chidambaran V, Sadhasivam S, Quinn C, Teusink-Cross A, et al.
Am J Health Syst Pharm
. 2023 Jan;
80(13):852-859.
PMID: 36715063
Purpose: We describe the implementation of CYP2D6-focused pharmacogenetic testing to guide opioid prescribing in a quaternary care, nonprofit pediatric academic medical center. Summary: Children are often prescribed oral opioids after...
10.
Jodele S, Dandoy C, Sabulski A, Koo J, Lane A, Myers K, et al.
Transplant Cell Ther
. 2022 May;
28(7):392.e1-392.e9.
PMID: 35490975
Transplantation-associated thrombotic microangiopathy (TA-TMA) can range from a self-limiting condition to a lethal transplantation complication. It is important to identify TA-TMA patients at risk for severe multiorgan endothelial injury to...